Hidden Risks of Weight Loss Jabs for Menopausal Women
So-called fat jabs have helped nearly four million Britons shed pounds, but experts warn they may pose hidden risks for menopausal women. A recent survey of more than 10,000 adults found that women aged 50 to 64 were most likely to use GLP-1 medications, with 20 percent reporting current or past use.
Studies show that patients on these injections often lose muscle or lean body mass alongside fat. For menopausal women, who already experience faster muscle decline, this can create dangerous health concerns, according to specialists.
Menopause and hormone health expert Dr Shirin Lakhani states that GLP-1s can reduce muscle mass and bone density. "If weight loss is not managed carefully, you risk losing not only body fat but also valuable muscle, which is essential for strength, mobility and healthy ageing," she tells Sun Health.
Dr Lakhani adds that practitioners should be hesitant to prescribe the injections to patients struggling with nutrition, significant muscle loss, osteoporosis, or rapid weight loss without effort. Osteoporosis affects more than 3.5 million people in the UK, with nearly two-thirds being women, and hip fractures claim an estimated 2,500 British lives every year.
Concerns Raised Over Bone Density and Muscle Mass
Dr Jack Mosley, son of the late broadcaster and health advocate Michael Mosley, also raised alarms on The Dr Louise Newton Podcast regarding side effects for menopausal women. He noted that the decline in oestrogen, testosterone, and progesterone during perimenopause and menopause already accelerates muscle loss and conditions like osteoporosis.
Common side effects of GLP-1 injections include nausea and diarrhoea, while rarer complications involve pancreatitis, vision loss, and allergic reactions. Women with a history of pancreatitis, gastroparesis, bowel obstruction, or gallbladder disease must consult their prescriber before starting the treatment.
Tragically, 58-year-old Susan McGowan passed away in 2024 after taking two low-dose injections of Mounjaro, suffering from pancreatitis, multiple organ failure, and septic shock. Her passing marked the first UK death officially linked to Mounjaro, though menopause was not cited as a contributing factor.
Impact on Oral Medications Like HRT and Contraceptive Pills
Early research indicates that weight loss treatments could interfere with other medications by slowing down digestion. Because GLP-1 drugs mimic fullness hormones and delay stomach emptying, oral drugs such as the contraceptive pill and hormone replacement therapy can experience delayed absorption.
Dr Crystal Wyllie, a general practitioner at Asda Online Doctor, explains that oral contraceptives and HRT often require precise timing, which gets disrupted by delayed digestion. She notes that doctors might recommend switching to non-oral forms of HRT, such as patches, gels, or sprays.
The British Menopause Society also advises women using GLP-1 medications for diabetes or obesity to opt for transdermal oestrogen instead of pills. Alcohol risks and side effects of taking fat jabs like Mounjaro and Wegovy highlight further health considerations for users.